Addressing Non-Uniform Coating in Enteric-Coated Tablets During Equipment Validation

Addressing Non-Uniform Coating in Enteric-Coated Tablets During Equipment Validation

Published on 29/12/2025

Addressing Non-Uniform Coating in Enteric-Coated Tablets During Equipment Validation

Introduction:

The pharmaceutical industry constantly seeks to improve the quality and efficacy of its products, with enteric-coated tablets playing a crucial role in protecting active ingredients from the acidic environment of the stomach. Achieving uniform coating during the equipment validation phase is essential to ensure the tablet’s performance and patient safety. This article provides an in-depth exploration of the challenges associated with non-uniform coating in enteric-coated tablets and presents a structured approach to addressing these issues during equipment validation.

Challenges and Issues:

  • Inconsistent Coating Thickness: Variability in the application of the coating material can lead to uneven protection and delayed drug release.
  • Adhesion Problems: Poor adhesion between the coating and the tablet core can result in coating flaking or peeling.
  • Surface Defects: Tablet surfaces may exhibit defects like roughness or orange peel effect, impacting the aesthetic and functional quality.
  • Formulation-Specific Challenges: The choice of coating materials and solvents can lead to drying issues and solvent entrapment, affecting uniformity.
Pharma Tip:  Preventing Tablet Chipping During Compression

Step-by-Step Troubleshooting Guide:

  1. Assess Equipment Calibration: Ensure that all coating equipment is properly calibrated. Regular calibration checks can prevent issues related to spray patterns and coating application rates.
  2. Optimize Coating Parameters: Evaluate and
adjust parameters such as spray rate, atomization air pressure, and drum speed to achieve a consistent coating. Consider using a Design of Experiments (DoE) approach to systematically explore these variables.
  • Monitor Environmental Conditions: Maintain appropriate temperature and humidity levels in the coating environment to prevent rapid drying or moisture-related issues.
  • Inspect Coating Solution Preparation: Ensure that the coating solution is homogeneously mixed and free from agglomerates. Use high-shear mixing if necessary.
  • Conduct In-Process Testing: Implement regular sampling and testing of tablets during the coating process to monitor thickness, adhesion, and surface quality.
  • Address Adhesion Issues: Evaluate the pretreatment of tablet cores, such as using sub-coating layers or primers, to improve adhesion.
  • Implement Process Validation: Validate the entire coating process by conducting multiple batches and analyzing the results for consistency and compliance with specifications.
  • Regulatory Guidelines:

    Adhering to regulatory guidelines is crucial for ensuring the quality and safety of enteric-coated tablets. The USFDA provides comprehensive guidelines on the validation of pharmaceutical manufacturing processes, including coating applications. These guidelines stress the importance of process validation, equipment calibration, and quality control measures to achieve uniform product quality.

    Conclusion:

    In addressing non-uniform coating in enteric-coated tablets during equipment validation, pharmaceutical professionals should focus on optimizing coating parameters, maintaining environmental control, and ensuring thorough equipment calibration. By adhering to regulatory guidelines and implementing robust quality control measures, manufacturers can enhance the reliability and effectiveness of their enteric-coated tablets. Continuous monitoring and process validation are key to overcoming the challenges and ensuring high-quality pharmaceutical products.

    Pharma Tip:  Preventing Tablet Breakage During High-Speed Compression